Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000
Modulation of HIV-1 replication by a novel RhoA effector activityL Wang, H Zhang, P A Solski, et al.
Biochemical Society Transactions|October 1, 1989
Activation of cellular p21ras by myristoylationJ E Buss, P A Solski, J P Schaeffer, et al.
Science (New York, N.Y.)|March 24, 1989
Activation of the cellular proto-oncogene product p21Ras by addition of a myristylation signalJ E Buss, P A Solski, J P Schaeffer, et al.
Molecular and Cellular Biology|October 1, 1994
Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic RasR Khosravi-Far, M Chrzanowska-Wodnicka, P A Solski, et al.
Oncogene|June 15, 1995
Critical role of Rho in cell transformation by oncogenic RasG C Prendergast, R Khosravi-Far, P A Solski, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1990
Farnesol modification of Kirsten-ras exon 4B protein is essential for transformationJ H Jackson, C G Cochrane, J R Bourne, et al.
The Journal of Biological Chemistry|January 9, 1999
A non-farnesylated Ha-Ras protein can be palmitoylated and trigger potent differentiation and transformationM A Booden, T L Baker, P A Solski, et al.
Molecular and Cellular Biology|July 1, 1996
Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformationR Khosravi-Far, M A White, J K Westwick, et al.
Pageof 3